Pseudomonas aeruginosa Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pseudomonas Aeruginosa Pneumonia pipeline market research report provides comprehensive information on the therapeutics under development for Pseudomonas Aeruginosa Pneumonia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Pseudomonas Aeruginosa Pneumonia and features dormant and discontinued projects.
Key Targets in the Pseudomonas Aeruginosa Pneumonia Pipeline Market
The key targets in the Pseudomonas Aeruginosa Pneumonia pipeline market are 30S Ribosomal Protein S10, Lipopolysaccharide, and LPS Assembly Protein LptD.
Key Types of MoA in the Pseudomonas Aeruginosa Pneumonia Pipeline Market
The key types of MoA in the Pseudomonas Aeruginosa Pneumonia pipeline market are 30S Ribosomal Protein S10 Inhibitor, Lipopolysaccharide Inhibitor, and LPS Assembly Protein LptD Inhibitor.
Key RoA Types in the Pseudomonas Aeruginosa Pneumonia Pipeline Market
The key RoA type in the Pseudomonas Aeruginosa Pneumonia pipeline market is intravenous.
Key Molecule Types in the Pseudomonas Aeruginosa Pneumonia Pipeline Market
The key molecule types in the Pseudomonas Aeruginosa Pneumonia pipeline market are antisense RNAi oligonucleotide, biologic, gene therapy, monoclonal antibody, recombinant enzyme, and small molecule. Antisense RNAi oligonucleotide has the highest pipeline products.
Pseudomonas Aeruginosa Pneumonia Pipeline Market, by Molecule Types
For more molecule type insights, download a free report sample
Key Companies in the Pseudomonas Aeruginosa Pneumonia Pipeline Market
The key companies in the Pseudomonas Aeruginosa Pneumonia pipeline market are Pedanius Therapeutics Ltd, Aridis Pharmaceuticals Inc, Armata Pharmaceuticals Inc, AstraZeneca Plc, and Ayuvis Research Inc. Pedanius Therapeutics Ltd has the highest pipeline products.
Pseudomonas Aeruginosa Pneumonia Pipeline Market, by Companies
For more company insights, download a free report sample
Market Report Overview
Key targets | 30S Ribosomal Protein S10, Lipopolysaccharide, and LPS Assembly Protein LptD |
Key types of MoA | 30S Ribosomal Protein S10 Inhibitor, Lipopolysaccharide Inhibitor, and LPS Assembly Protein LptD Inhibitor |
Key RoA type | Intravenous |
Key molecule types | Antisense RNAi Oligonucleotide, Biologic, Gene Therapy, Monoclonal Antibody, Recombinant Enzyme, and Small Molecule |
Key companies | Pedanius Therapeutics Ltd, Aridis Pharmaceuticals Inc, Armata Pharmaceuticals Inc, AstraZeneca Plc, and Ayuvis Research Inc |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Pseudomonas Aeruginosa Pneumonia (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Pseudomonas Aeruginosa Pneumonia (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Pseudomonas Aeruginosa Pneumonia (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Pseudomonas Aeruginosa Pneumonia (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Pseudomonas Aeruginosa Pneumonia (Infectious Disease)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Pseudomonas Aeruginosa Pneumonia (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Pseudomonas Aeruginosa Pneumonia (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Armata Pharmaceuticals Inc
AstraZeneca Plc
Ayuvis Research Inc
Pedanius Therapeutics Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Pseudomonas Aeruginosa Pneumonia pipeline market?
The key targets in the Pseudomonas Aeruginosa Pneumonia pipeline market are 30S Ribosomal Protein S10, Lipopolysaccharide, and LPS Assembly Protein LptD.
-
What are the key types of MoA in the Pseudomonas Aeruginosa Pneumonia pipeline market?
The key types of MoA in the Pseudomonas Aeruginosa Pneumonia pipeline market are 30S Ribosomal Protein S10 Inhibitor, Lipopolysaccharide Inhibitor, and LPS Assembly Protein LptD Inhibitor.
-
What is the key RoA type in the Pseudomonas Aeruginosa Pneumonia pipeline market?
The key RoA type in the Pseudomonas Aeruginosa Pneumonia pipeline market is intravenous.
-
What are the key molecule type in the Pseudomonas Aeruginosa Pneumonia pipeline market?
The key molecule types in the Pseudomonas Aeruginosa Pneumonia pipeline market are antisense RNAi oligonucleotide, biologic, gene therapy, monoclonal antibody, recombinant enzyme, and small molecule.
-
What are the key companies in the Pseudomonas Aeruginosa Pneumonia pipeline market?
The key companies in the Pseudomonas Aeruginosa Pneumonia pipeline market are Pedanius Therapeutics Ltd, Aridis Pharmaceuticals Inc, Armata Pharmaceuticals Inc, AstraZeneca Plc, and Ayuvis Research Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.